stem cell property
Recently Published Documents


TOTAL DOCUMENTS

17
(FIVE YEARS 0)

H-INDEX

9
(FIVE YEARS 0)

2020 ◽  
Vol 7 (22) ◽  
pp. 2001417
Author(s):  
Yuncheng Bei ◽  
Nan Cheng ◽  
Ting Chen ◽  
Yuxin Shu ◽  
Ye Yang ◽  
...  

2019 ◽  
Vol 116 (41) ◽  
pp. 20528-20538 ◽  
Author(s):  
Yuan Yin ◽  
Chuan-Ming Xie ◽  
Hua Li ◽  
Mingjia Tan ◽  
Guoan Chen ◽  
...  

SOX2 is a key transcription factor that plays critical roles in maintaining stem cell property and conferring drug resistance. However, the underlying mechanisms by which SOX2 level is precisely regulated remain elusive. Here we report that MLN4924, also known as pevonedistat, a small-molecule inhibitor of neddylation currently in phase II clinical trials, down-regulates SOX2 expression via causing accumulation of MSX2, a known transcription repressor of SOX2 expression. Mechanistic characterization revealed that MSX2 is a substrate of FBXW2 E3 ligase. FBXW2 binds to MSX2 and promotes MSX2 ubiquitylation and degradation. Likewise, FBXW2 overexpression shortens the protein half-life of MSX2, whereas FBXW2 knockdown extends it. We further identified hypoxia as a stress condition that induces VRK2 kinase to facilitate MSX2–FBXW2 binding and FBXW2-mediated MSX2 ubiquitylation and degradation, leading to SOX2 induction via derepression. Biologically, expression of FBXW2 or SOX2 promotes tumor sphere formation, which is blocked by MSX2 expression. By down-regulating SOX2 through inactivation of FBXW2 E3 ligase, MLN4924 sensitizes breast cancer cells to tamoxifen in both in vitro and in vivo cancer cell models. Thus, a negative cascade of the FBXW2–MSX2–SOX2 axis was established, which regulates stem cell property and drug resistance. Finally, an inverse correlation of expression was found between FBXW2 and MSX2 in lung and breast cancer tissues. Collectively, our study revealed an anticancer mechanism of MLN4924. By inactivating FBXW2, MLN4924 caused MSX2 accumulation to repress SOX2 expression, leading to suppression of stem cell property and sensitization of breast cancer cells to tamoxifen.


2018 ◽  
Vol Volume 11 ◽  
pp. 6657-6663 ◽  
Author(s):  
Aiyue Zhao ◽  
Yijun Dai ◽  
Jianfeng Lian ◽  
Yan Huang ◽  
Jianguang Lin ◽  
...  

2016 ◽  
Author(s):  
Kenjiro Kimura ◽  
Kotaro Miura ◽  
Ryosuke Amano ◽  
Sadaaki Yamazoe ◽  
Naoki Kametani ◽  
...  

2016 ◽  
Vol 5 ◽  
pp. 1-10 ◽  
Author(s):  
Naoya Murao ◽  
Hirofumi Noguchi ◽  
Kinichi Nakashima

2016 ◽  
Vol 2016 ◽  
pp. 1-14 ◽  
Author(s):  
Lin-Lin Lu ◽  
Xiao-Hui Chen ◽  
Ge Zhang ◽  
Zong-Cai Liu ◽  
Nong Wu ◽  
...  

Some evidence indicated that chemoresistance associates with the acquisition of cancer stem-like properties. Recent studies suggested that chemokines can promote the chemoresistance and stem cell properties in various cancer cells, while the underling mechanism is still not completely illustrated. In our study, we found that CCL21 can upregulate the expression of P-glycoprotein (P-gp) and stem cell property markers such as Bmi-1, Nanog, and OCT-4 in colorectal cancer (CRC) HCT116 cells and then improve the cell survival rate and mammosphere formation. Our results suggested that Snail was crucial for CCL21-mediated chemoresistance and cancer stem cell property in CRC cells. Further, we observed that CCL21 treatment increased the protein but not mRNA levels of Snail, which suggested that CCL21 upregulates Snail via posttranscriptional ways. The downstream signals AKT/GSK-3βmediated CCL21 induced the upregulation of Snail due to the fact that CCL21 treatment can obviously phosphorylate both AKT and GSK-3β. The inhibitor of PI3K/Akt, LY294002 significantly abolished CCL21 induced chemoresistance and mammosphere formation of HCT116 cells. Collectively, our results in the present study revealed that CCL21 can facilitate chemoresistance and stem cell property of CRC cells via the upregulation of P-gp, Bmi-1, Nanog, and OCT-4 through AKT/GSK-3β/Snail signals, which suggested a potential therapeutic approach to CRC patients.


Sign in / Sign up

Export Citation Format

Share Document